Europe
Azeria Therapeutics Limited, a newly formed drug discovery company, today announced the appointment of Dr Julian Blagg as VP Drug Discovery.
Findings support development of γδ T cells for gastrointestinal diseases
MC Services AG is, once again, sponsoring the “Deutsches Eigenkapitalforum” (German Equity Forum) and will host the event’s press lounge. The Forum will be held in Frankfurt am Main, November 26-28, 2018.
Sareum Holdings plc is pleased to announce the appointments of Michael Owen, PhD and Clive Birch as Non-Executive Directors.
BioArctic AB will present at Jefferies 2018 London Healthcare Conference on November 15, at 4.40 p.m. local time (GMT).
BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients. AbbVie exercises its option to a license for Parkinson’s projects
Medigene AG today reported financial results for the first 9 months of 2018 and provided a review of recent accomplishments and anticipated upcoming milestones.
Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its new generation G:BOX Chemi XX6/XX9 multi-application imaging systems are now available. Featuring the latest, ultra-sensitive, fast capture lens, these systems ensure scientists can have total confidence that their gel and blot results are accurate and publication-ready.
One company, Life Biosciences, is taking a broad—yet also specific—approach to longevity and diseases of aging. Co-founder and chairman David Sinclair took time to talk to BioSpace about the company.
A Small Group of Pharma Companies Is Making the Bulk of Medicines Necessary for Developing Countries
There are 7 billion people in the world. Of those, 5 billion have access to life-saving medications, while 2 billion do not. That is a gap that pharmaceutical companies can help close through increased R&D programs, logistical initiatives and the lowering of prices, the Access to Medicine Foundation announced Tuesday.
PRESS RELEASES